Lou Gehrig’s Disease (ALS): UCSD Team’s Stem Cell Therapy Rationale

Posted: Published on June 23rd, 2011

This post was added by Dr Simmons



(Part 3 of 8) Don Cleveland, Ph.D. spoke at the "Spotlight on Disease Team Awards: ALS," an educational event presented at the CIRM Governing Board meeting on June 23, 2010. Goldstein is a co-principle investigator of the CIRM ALS Disease Team and member of The Ludwig Institute.

Go here to read the rest:
Lou Gehrig's Disease (ALS): UCSD Team's Stem Cell Therapy Rationale

This entry was posted in Uncategorized. Bookmark the permalink.

Comments are closed.